• Company Type For Profit
  • Contact Email Ekosmarketing@ekoscorp.com
  • Phone Number 4254153102

EKOS Corporation pioneered the development and the clinical application of ultrasound accelerated thrombolysis, introducing its first system for the treatment of vascular thrombosis in 2005. Today, interventional radiologists, cardiologists and vascular surgeons at leading institutions around the world use the EKOS EkoSonic Endovascular System to

provide faster, safer and more complete dissolution of thrombus.

Lists Featuring This Company

Morgan Stanley Portfolio Companies
234 Number of Organizations • $334.4B Total Funding Amount • 2,727 Number of Investors
University of California Berkeley Alumni Founded Companies
5,187 Number of Organizations • $182.4B Total Funding Amount • 16,005 Number of Investors
Acquired Health Care Companies (Top 10K)
9,789 Number of Organizations • $228.1B Total Funding Amount • 14,960 Number of Investors
Acquired Western US Companies (Top 10K)
9,893 Number of Organizations • $446.2B Total Funding Amount • 36,167 Number of Investors
EKOS Corporation was acquired by BTG International for $220M on May 23, 2013.

Frequently Asked Questions

Where is EKOS Corporation's headquarters? EKOS Corporation is located in Bothell, Washington, United States.Who invested in EKOS Corporation? EKOS Corporation has 10 investors including Mitsui Global Investment and NGN Capital.How much funding has EKOS Corporation raised to date? EKOS Corporation has raised .When was the last funding round for EKOS Corporation? EKOS Corporation closed its last funding round on Mar 27, 2008 from a Series C round.Who are EKOS Corporation's competitors? Alternatives and possible competitors to EKOS Corporation may include Osciflex and MedGate.